68_PARAGRAPHS

Estrogen receptor-beta has been detected in the oral mucosa
and salivary glands (Valimaa et al., 2004), and some evidence
shows age-related hormonal changes in the exfoliated normal
buccal mucosa of women (Donald et al., 2013). Moreover, the
vaginal and buccal epithelia share some microscopic similarities.
As observed by Thompson et al.  the patterns of surface
keratinization and the distribution and appearance of
the
lipid lamellae in the intercellular spaces were similar between
vaginal and buccal epithelial samples of postmenopausal women.
Therefore, given that many menopausal women also suﬀer from
oral discomforts in addition to climacteric symptoms (Meurman
et al., 2009), an understanding of the impact of female sex.

September 2017 | Volume 8 | Article 1884.

Periodontitis is a chronic inﬂammatory process that occurs
in response to an increase in Gram-negative bacteria in the
bioﬁlm (Ruby and Barbeau, 2002), aﬀecting the tissues that
surround and support the teeth. Speciﬁc bacterial species, such
as Porphyromonas gingivalis and Tannerella forsythensis, were
found to be important
in the etiology of periodontitis in
postmenopausal women (Brennan et al., 2007). In addition,
changes in periodontal status were found to be associated
with variations in sex hormone levels (Mascarenhas et al.,
2003), and the occurrence of periodontitis was reported to be
greater in postmenopausal women who did not receive hormone
replacement than in premenopausal women (Haas et al., 2009).
Therefore, from a clinical point of view, the roles of sex hormones
and hormone therapy in the prevalence of subgingival bacterial
infection in peri- and postmenopausal women are of great
interest..

In a cohort study that included 106 women aged 50–58 years,
hormone replacement therapy led to a decreased number of
positive samples showing the periodontal pathogens P. gingivalis,
Prevotella intermedia, and T.
forsythia from the subgingival
plaque (Tarkkila et al., 2010). Consistent with this result, a
previous study found improved periodontal probing depths and
tooth mobility in 190 randomized women who received hormone
therapy for 1 year (López-Marcos et al., 2005). Conversely,
Pilgram et al. investigated 135 women in a randomized,
controlled trial who received estrogen replacement for 3 years
and did not ﬁnd any changes in clinical parameters such as the
attachment of teeth or the bone mineral density of the lumbar
spine. In mice, estrogen seems to modulate IL-1 production
and participate in the resistance of females to disseminating
dentoalveolar infections, leading to the enhanced localization
of these infections (Youssef and Stashenko, 2017), which draws
attention to the potential role of sex-related hormones in the
modulation of oral mucosal infections..

As mentioned earlier, female sex hormones levels inﬂuence
the composition of the microbiota in many sites of the body,
especially the gut. Due to intimate contact with the larger gut
immune system, the gut microbiota has been shown to inﬂuence
many diseases outside of this organ (Figure 1). Accordingly,
imbalance of the gut microbiota, called dysbiosis, has been
extensively related to metabolic and immunological diseases.
Interestingly, the presence or absence of estrogen may be able
to alter the gut microbiota equilibrium and corresponding
disease pathways. Some autoimmune diseases aﬀect more often
women than men, including systemic lupus erythematosus (Jiang
et al., 2005), Sjogren’s syndrome (Patel and Shahane, 2014)
and rheumatoid arthritis (Oliver and Silman, 2009). Gender
diﬀerences have also been reported for the outcome of microbial
infections (Fischer et al., 2015). Interestingly, the onset of
autoimmune diseases, asthma (Akinbami et al., 2016) and other
diseases occurs after menarche or during the reproductive
period of women. Experimental ﬁndings in mice have shown
that
female sexual
hormones, and immunity are associated with the development
of autoimmune diseases (Yurkovetskiy et al., 2013, 2015),
including type 1 diabetes (Markle et al., 2013) and rheumatoid
arthritis (Wu et al., 2010). The non-obese diabetic (NOD)
mouse exhibits spontaneous, immune-mediated pancreatic beta
cell destruction causing type 1 diabetes (T1D) with a complex
genetic and environmental etiology. The NOD T1D incidence
shows a strong 2:1 female to male sex bias (Markle et al., 2013).
Interestingly, germ-free NOD female mice lack this gender bias
for diabetes. Additionally, after castration, males exhibit a similar
microbiota composition and T1D incidence to females (Markle
et al., 2013). In general, this study shows that the microbiome
is a causal factor and not simply a consequence of autoimmune
disease..

September 2017 | Volume 8 | Article 1884.

Another link between the gut microbiome and menopausal
health is related to bone. Interesting, the gut microbiota has
also been found to inﬂuence bone homeostasis. Approximately
one in two women over age 50 will break a bone because of
osteoporosis. A study that involved twenty postmenopausal
women with a mean age of 65 years showed that the group
that consumed Lactobacillus helveticus-fermented milk had
increased serum calcium levels and reduced bone reabsorption
compared with those of the control milk consumption group
(Narva et al., 2004). Experimental studies have also demonstrated
similar results. For instance, L. reuteri treatment signiﬁcantly
protected ovariectomized mice from bone loss and increases
in bone marrow CD4+ T-lymphocytes, which promote
osteoclastogenesis (Britton et al., 2014). Another study that
investigated probiotic treatment for cortical bone loss found
two inﬂammatory cytokines, TNF-α
reduced expression of
and IL-1β, and increased expression of osteoprotegerin, a
potent inhibitor of osteoclastogenesis, in the cortical bone of
ovariectomized mice (Ohlsson et al., 2014). Additionally, sex
steroid deprivation has been reported to promote intestinal
permeability (Figure 1), and the oral administration of
L. rhamnosus GG (LGG) or VSL#3 (a combination of tree
probiotics) to estrogen-deﬁcient mice signiﬁcantly reinforced
intestinal barrier integrity and completely protected the mice
against sex steroid depletion-induced bone loss (Li et al., 2016).
Importantly, to conﬁrm the role of the gut microbiota in bone
health, another experiment also showed that germ-free mice are
protected against the bone loss induced by the absence of sex
steroids (Li et al., 2016)..

FIGURE 1 | Female sexual hormones levels inﬂuence the composition of the
microbiota in many sites of the body, especially mouth and gut. The oral and
gut microbiota have been shown to inﬂuence many diseases, such as
osteoporosis, weight gain and lipid deposition, breast cancer and
periodontitis..

September 2017 | Volume 8 | Article 1884.

Akinbami, L. J., Simon, A. E., and Schoendorf, K. C.  Trends in allergy
prevalence among children aged 0−17 years by asthma status, United States,
2001−2013. J. Asthma 53, 356–362. doi: 10.3109/02770903.2015.1126848
Allaker, R. P., and Ian Douglas, C. W.  Non-conventional therapeutics for.

Almstahl, A., Carlen, A., Eliasson, L., and Lingstrom, P.  Lactobacillus
species in supragingival plaque in subjects with hyposalivation. Arch. Oral. Biol.
55, 255–259. doi: 10.1016/j.archoralbio.2010.01.007.

Britton, R. A., Irwin, R., Quach, D., Schaefer, L., Zhang, J., Lee, T., et al.
 Probiotic L. reuteri treatment prevents bone loss in a menopausal
ovariectomized mouse model. J. Cell. Physiol. 229, 1822–1830. doi: 10.1002/jcp.
24636.

Aloia, J. F., Vaswani, A., Russo, L., Sheehan, M., and Flaster, E.  The inﬂuence
of menopause and hormonal replacement therapy on body cell mass and body
fat mass. Am. J. Obstet. Gynecol. 172, 896–900. doi: 10.1016/0002-9378
90018-7.

Brotman, R. M., Shardell, M. D., Gajer, P., Fadrosh, D., Chang, K., Silver, M. I.,
et al.  Association between the vaginal microbiota, menopause status,
and signs of vulvovaginal atrophy. Menopause 21, 450–458. doi: 10.1097/GME.
0b013e3182a4690b.

Arimatsu, K., Yamada, H., Miyazawa, H., Minagawa, T., Nakajima, M., Ryder,
M. I., et al.  Oral pathobiont induces systemic inﬂammation and
metabolic changes associated with alteration of gut microbiota. Sci. Rep. 4:4828.
doi: 10.1038/srep04828.

Cao, M., Shu, L., Li, J., Su, J., Zhang, W., Wang, Q., et al.  The expression of
estrogen receptors and the eﬀects of estrogen on human periodontal ligament
cells. Methods Find. Exp. Clin. Pharmacol. 29, 329–335. doi: 10.1358/mf.2007.
29.5.1117560.

Chen, K. L., and Madak-Erdogan, Z.  Estrogen and microbiota crosstalk:
should we pay attention? Trends Endocrinol. Metab. 27, 752–755. doi: 10.1016/
j.tem.2016.08.001.

Backhed, F.  Host responses to the human microbiome. Nutr. Rev..

Belenguer, A., Duncan, S. H., Calder, A. G., Holtrop, G., Louis, P., Lobley, G. E.,
et al.  Two routes of metabolic cross-feeding between Biﬁdobacterium
adolescentis and butyrate-producing anaerobes
from the human gut.
Appl. Environ. Microbiol. 72, 3593–3599. doi: 10.1128/AEM.72.5.3593-
3599.2006.

Belstrom, D., Holmstrup, P., Fiehn, N. E., Rosing, K., Bardow, A., Paster, B. J.,
et al.  Bacterial composition in whole saliva from patients with severe
hyposalivation–a case-control study. Oral Dis. 22, 330–337. doi: 10.1111/odi.
12452.

Belstrøm, D., Holmstrup, P., Nielsen, C. H., Kirkby, N., Twetman, S., Heitmann,
B. L., et al.  Bacterial proﬁles of saliva in relation to diet, lifestyle
factors, and socioeconomic status. J. Oral Microbiol. 6. doi: 10.3402/jom.v6.
23609.

Cordina-Duverger, E., Truong, T., Anger, A., Sanchez, M., Arveux, P., Kerbrat, P.,
et al.  Weight and weight changes throughout life and postmenopausal
breast cancer risk: a case-control study in France. BMC Cancer 16:761.
doi: 10.1186/s12885-016-2793-0.

Curtis, M. A., Zenobia, C., and Darveau, R. P.  The relationship of the oral
microbiotia to periodontal health and disease. Cell Host Microbe 10, 302–306.
doi: 10.1016/j.chom.2011.09.008.

Ding, T., and Schloss, P. D.  Dynamics and associations of microbial
community types across the human body. Nature 509, 357–360. doi: 10.1038/
nature13178.

Dutt, P., Chaudhary, S., and Kumar, P.  Oral health and menopause:
a comprehensive review on current knowledge and associated dental
management. Ann. Med. Health Sci. Res. 3, 320–323. doi: 10.4103/2141-9248.
117926.

September 2017 | Volume 8 | Article 1884.

Fischer, J., Jung, N., Robinson, N., and Lehmann, C.  Sex diﬀerences in
immune responses to infectious diseases. Infection 43, 399–403. doi: 10.1007/
s15010-015-0791-9.

Frankenfeld, C. L., Atkinson, C., Wahala, K., and Lampe, J. W.  Obesity
prevalence in relation to gut microbial environments capable of producing
equol or O-desmethylangolensin from the isoﬂavone daidzein. Eur. J. Clin.
Nutr. 68, 526–530. doi: 10.1038/ejcn.2014.23.

Frankenfeld, C. L., McTiernan, A., Aiello, E. J., Thomas, W. K., LaCroix, K.,
Schramm, J., et al.  Mammographic density in relation to daidzein-
metabolizing phenotypes in overweight, postmenopausal women. Cancer
Epidemiol. Biomarkers Prev. 13, 1156–1162..

Leeners, B., Geary, N., Tobler, P. N., and Asarian, L.  Ovarian hormones and
obesity. Hum. Reprod. Update 23, 300–321. doi: 10.1093/humupd/dmw045
Li, J. Y., Chassaing, B., Tyagi, A. M., Vaccaro, C., Luo, T., Adams, J., et al.  Sex
steroid deﬁciency-associated bone loss is microbiota dependent and prevented
by probiotics. J. Clin. Invest. 126, 2049–2063. doi: 10.1172/JCI86062.

Liu, B., Faller, L. L., Klitgord, N., Mazumdar, V., Ghodsi, M., Sommer, D. D.,
et al.  Deep sequencing of the oral microbiome reveals signatures
of periodontal disease. PLOS ONE 7:e37919. doi: 10.1371/journal.pone.
0037919.

Lobo, R. A., Davis, S. R., De Villiers, T. J., Gompel, A., Henderson, V. W., Hodis,
H. N., et al.  Prevention of diseases after menopause. Climacteric 17,
540–556. doi: 10.3109/13697137.2014.933411.

López-Marcos, J. F., García-Valle, S., and García-Iglesias, A. A.  Periodontal
aspects in menopausal women undergoing hormone replacement therapy. Med.
Oral Patol. Oral Cir. Bucal 10, 132–141..

Genco, R. J., Grossi, S. G., Ho, A., Nishimura, F., and Murayama, Y. 
A proposed model linking inﬂammation to obesity, diabetes, and periodontal
infections. J. Periodontol. 76 11(Suppl.), 2075–2084. doi: 10.1902/jop.2005.76.
11-S.2075.

Markle, J. G., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M.,
Rolle-Kampczyk, U., et al.  Sex diﬀerences in the gut microbiome drive
hormone-dependent regulation of autoimmunity. Science 339, 1084–1088.
doi: 10.1126/science.1233521.

Grover, M., and Kashyap, P. C.  Germ-free mice as a model to study eﬀect
of gut microbiota on host physiology. Neurogastroenterol. Motil. 26, 745–748.
doi: 10.1111/nmo.12366.

Hernandez-Vigueras, S., Martinez-Garriga, B., Sanchez, M. C., Sanz, M., Estrugo-
Devesa, A., Vinuesa, T., et al.  Oral microbiota, periodontal status,
and osteoporosis in postmenopausal females. J. Periodontol. 87, 124–133.
doi: 10.1902/jop.2015.150365.

Hoﬀmann, J. C., Zeitz, M., Bischoﬀ, S. C., Brambs, H. J., Bruch, H. P., Buhr,
H. J., et al.  [Diagnosis and therapy of ulcerative colitis: results of
an evidence based consensus conference by the German society of digestive
and metabolic diseases and the competence network on inﬂammatory bowel
disease]. Z. Gastroenterol. 42, 979–983. doi: 10.1055/s-2004-813510.

Hullar, M. A., Burnett-Hartman, A. N., and Lampe, J. W.  Gut microbes,
diet, and cancer. Cancer Treat. Res. 159, 377–399. doi: 10.1007/978-3-642-
38007-5_22.

Jenkinson, H. F., and Lamont, R. J.  Oral microbial communities in sickness
and in health. Trends Microbiol. 13, 589–595. doi: 10.1016/j.tim.2005.09.006
Jiang, J. F., Liu, Y. H., and Zhang, C. X.  [Sex hormones in female patients
with systemic lupus erythematosus]. Zhong Nan Da Xue Xue Bao Yi Xue Ban
30, 315–317..

Joshipura, K. J., Rimm, E. B., Douglass, C. W., Trichopoulos, D., Ascherio, A., and
Willett, W. C.  Poor oral health and coronary heart disease. J. Dent. Res.
75, 1631–1636. doi: 10.1177/00220345960750090301.

Key, T. J., Appleby, P. N., Reeves, G. K., Roddam, A., Dorgan, J. F., Longcope, C.,
et al.  Body mass index, serum sex hormones, and breast cancer risk in
postmenopausal women. J. Natl. Cancer Inst. 95, 1218–1226. doi: 10.1093/jnci/
djg022.

Kwa, M., Plottel, C. S., Blaser, M. J., and Adams, S.  The Intestinal
microbiome and estrogen receptor-positive female breast cancer. J. Natl. Cancer
Inst 108. doi: 10.1093/jnci/djw029.

Lago, M. L., de Oliveira, A. E., Lopes, F. F., Ferreira, E. B., Rodrigues, V. P., and
Brito, L. M.  The inﬂuence of hormone replacement therapy on the
salivary ﬂow of post-menopausal women. Gynecol. Endocrinol. 31, 109–112.
doi: 10.3109/09513590.2014.959918.

Marsh, P. D., Do, T., Beighton, D., and Devine, D. A.  Inﬂuence of saliva on.

Mascarenhas, P., Gapski, R., Al-Shammari, K., and Wang, H. L.  Inﬂuence
of sex hormones on the periodontium. J. Clin. Periodontol. 30, 671–681.
doi: 10.1034/j.1600-051X.2003.00055.x.

Meurman, J. H., Tarkkila, L., and Tiitinen, A.  The menopause and oral.

Michaud, D. S., Fu, Z., Shi, J., and Chung, M.  Periodontal disease, tooth
loss, and cancer risk. Epidemiol. Rev. 39, 49–58. doi: 10.1093/epirev/mxx006
Miller, L. M., Lampe, J. W., Newton, K. M., Gundersen, G., Fuller, S., Reed, S. D.,
et al.  Being overweight or obese is associated with harboring a gut
microbial community not capable of metabolizing the soy isoﬂavone daidzein
to O-desmethylangolensin in peri- and post-menopausal women. Maturitas 99,
37–42. doi: 10.1016/j.maturitas.2017.02.006.

Nakatsu, C. H., Armstrong, A., Clavijo, A. P., Martin, B. R., Barnes, S., and Weaver,
C. M.  Fecal bacterial community changes associated with isoﬂavone
metabolites in postmenopausal women after soy bar consumption. PLOS ONE
9:e108924. doi: 10.1371/journal.pone.0108924.

Narva, M., Nevala, R., Poussa, T., and Korpela, R.  The eﬀect of
Lactobacillus helveticus fermented milk on acute changes in calcium metabolism
in postmenopausal women. Eur. J. Nutr. 43, 61–68. doi: 10.1007/s00394-004-
0441-y.

Nasidze, I., Li, J., Quinque, D., Tang, K., and Stoneking, M.  Global diversity
in the human salivary microbiome. Genome Res. 19, 636–643. doi: 10.1101/gr.
084616.108.

Oﬀenbacher, S., Jared, H. L., O’Reilly, P. G., Wells, S. R., Salvi, G. E., Lawrence,
H. P., et al.  Potential pathogenic mechanisms of periodontitis associated
pregnancy complications. Ann. Periodontol. 3, 233–250. doi: 10.1902/annals.
1998.3.1.233.

Ohlsson, C., Engdahl, C., Fak, F., Andersson, A., Windahl, S. H., Farman, H. H.,
et al.  Probiotics protect mice from ovariectomy-induced cortical bone
loss. PLOS ONE 9:e92368. doi: 10.1371/journal.pone.0092368.

Oliver, J. E., and Silman, A. J.  Why are women predisposed to autoimmune.

Patel, R., and Shahane, A.  The epidemiology of Sjogren’s syndrome. Clin..

Pilgram, T. K., Hildebolt, C. F., Dotson, M., Cohen, S. C., Hauser, J. F.,
Kardaris, E., et al.  Relationships between clinical attachment level and.

September 2017 | Volume 8 | Article 1884.

Ruby, J., and Barbeau, J.  The buccale puzzle: The symbiotic nature
of endogenous infections of the oral cavity. Can. J. Infect. Dis. 13, 34–41.
doi: 10.1155/2002/492656.

Sanz, M., Beighton, D., Curtis, M. A., Cury, J. A., Dige, I., Dommisch, H., et al.
 Role of microbial bioﬁlms in the maintenance of oral health and in
the development of dental caries and periodontal diseases. Consensus report
of group 1 of the Joint EFP/ORCA workshop on the boundaries between
caries and periodontal disease. J. Clin. Periodontol. 44(Suppl. 18), S5–S11.
doi: 10.1111/jcpe.12682
J., Terry,
III, and Heiss, G..

Suresh, L., and Radfar, L.  Pregnancy and lactation. Oral Surg. Oral Med.
Oral Pathol. Oral Radiol. Endod. 97, 672–682. doi: 10.1016/S1079210404000861
Tarkkila, L., Kari, K., Furuholm, J., Tiitinen, A., and Meurman, J. H. 
Periodontal disease-associated micro-organisms in peri-menopausal and
post-menopausal women using or not using hormone replacement therapy.
A two-year follow-up study. BMC Oral Health 10:10. doi: 10.1186/1472-
6831-10-10.

Uehara, M.  Isoﬂavone metabolism and bone-sparing eﬀects of daidzein-.

Valimaa, H., Savolainen, S., Soukka, T., Silvoniemi, P., Makela, S., Kujari, H.,
et al.  Estrogen receptor-beta is the predominant estrogen receptor
subtype in human oral epithelium and salivary glands. J. Endocrinol. 180, 55–62.
doi: 10.1677/joe.0.1800055.

Wang, A., Wang, C. P., Tu, M., and Wong, D. T.  Oral bioﬂuid biomarker
research: current status and emerging frontiers. Diagnostics 6:45. doi: 10.3390/
diagnostics6040045.

Wu, H. J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., et al. 
Gut-residing segmented ﬁlamentous bacteria drive autoimmune arthritis via T
helper 17 cells. Immunity 32, 815–827. doi: 10.1016/j.immuni.2010.06.001
Yost, S., Duran-Pinedo, A. E., Teles, R., Krishnan, K., and Frias-Lopez, J.
 Functional signatures of oral dysbiosis during periodontitis progression
revealed by microbial metatranscriptome analysis. Genome Med. 7, 27.
doi: 10.1186/s13073-015-0153-3.

Youssef, H., and Stashenko, P.  Interleukin-1 and estrogen protect against
disseminating dentoalveolar infections. Int. J. Oral Sci. 9, 16–23. doi: 10.1038/
ijos.2016.61.

Yurkovetskiy, L., Burrows, M., Khan, A. A., Graham, L., Volchkov, P., Becker, L.,
et al.  Gender bias in autoimmunity is inﬂuenced by microbiota.
Immunity 39, 400–412. doi: 10.1016/j.immuni.2013.08.013.

Yurkovetskiy, L. A., Pickard, J. M., and Chervonsky, A. V.  Microbiota
and autoimmunity: exploring new avenues. Cell Host Microbe 17, 548–552.
doi: 10.1016/j.chom.2015.04.010.

September 2017 | Volume 8 | Article 1884